Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
about
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
description
im August 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 10 August 2007
@en
wetenschappelijk artikel
@nl
name
Imatinib mesylate therapy in c ...... mplete molecular response rate
@en
Imatinib mesylate therapy in c ...... mplete molecular response rate
@nl
type
label
Imatinib mesylate therapy in c ...... mplete molecular response rate
@en
Imatinib mesylate therapy in c ...... mplete molecular response rate
@nl
prefLabel
Imatinib mesylate therapy in c ...... mplete molecular response rate
@en
Imatinib mesylate therapy in c ...... mplete molecular response rate
@nl
P2093
P1433
P1476
Imatinib mesylate therapy in c ...... mplete molecular response rate
@en
P2093
Barbara Izzo
Bruno Rotoli
Daniela Diverio
Fabrizio Pane
Fabrizio Quarantelli
Franco Mandelli
Giuliana Alimena
Ida Carmosino
Luigia Luciano
Marco Mancini
P304
P356
10.1016/J.LEUKRES.2007.06.008
P577
2007-08-10T00:00:00Z